Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05338346
Title	A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies (ATRIUM)
Acronym	ATRIUM
Recruitment	Terminated
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Antengene Discovery Limited
Indications	Advanced Solid Tumor diffuse large B-cell lymphoma follicular lymphoma marginal zone lymphoma splenic marginal zone lymphoma
Therapies	ATG-018
Age Groups:	senior \| adult
Covered Countries	AUS